We aimed to elucidate the role of the Ca-independent PKC isoenzyme PKCdelta in the regulation of spontaneous in vitro chondrogenesis occurring in a 6-day-long culturing period in chicken limb budderived high density cell cultures (HDC). PKCdelta expression and activity were detectable throughout the entire culturing period with a peak on days 2 and 3, when most of the chondroblasts differentiate. To inhibit the activity of PKCdelta, either the natural compound rottlerin was transiently applied to the culture medium of HDC in 2.5, 5 or 10 mM concentrations, or gene silencing was performed by using PKCdelta shRNA. Rottlerin significantly reduced the overall PKC activity in enzyme activity assays of cell-free samples of untreated control HDC, probably via the inhibition of PKCdelta. On the contrary, we were unable to detect any consistent change of PKC enzyme activity assayed in samples of HDC treated with rottlerin during culturing. PKCdelta gene silencing resulted in a significantly lower PKC activity. Both rottlerin and PKCdelta shRNA caused a severe reduction in cartilage formation, further more protein and phospho-protein levels of Sox9, the key transcription factor of chondrogenesis, were also significantly decreased. Rottlerin lowered, while PKCdelta gene silencing elevated the phosphorylation status of ERK1/2. Our data suggest that PKCdelta stimulates chondrogenesis via influencing Sox9 and ERK1/2 phosphorylation, but the inhibition of cartilage formation in the rottlerin-treated HDC is probably PKCdelta independent and rottlerin might have different effects when applied to cells or to an in vitro enzyme activity assay.
Introduction
During vertebrate limb development, at the onset of the multistep process of endochondral bone formation, undifferentiated chondroprogenitor mesenchymal cells first undergo a condensation phase characterised by rapid proliferation of cells. As a result, chondrogenic mesenchymal cells become closely packed, which initiates a complex and a yet not fully understood signalling mechanism that governs differentiation of cells within these condensations into chondroblasts and then mature chondrocytes [1] . Among a number of signalling molecules, members of the phospholipid-dependent serine/threonine protein kinase C (PKC) family are known regulators of in vitro chondrogenesis [2, 3] .
PKCs, present in almost all cell types, are involved in the regulation of various cellular processes. All known 11 PKC isoforms are divided into three subgroups based on their N-terminal regulatory domains and mechanism of activation: classical PKCs (cPKC; PKCalpha, betaI, betaII and gamma), novel PKCs (nPKC; PKCdelta, epsilon, eta and theta) and atypical PKCs (aPKC; PKCzeta, iota/ lambda and mu or PKD) [4] . The activation of PKCdelta also requires lipid second messengers (e.g. DAG) or tumour-promoting phorbol esters (e.g. PMA) without the requirement of Ca 2þ . Moreover, PKCdelta exhibits tyrosine-phosphorylation sites, which are targets Abbreviations: BMP, bone morphogenic protein; BSA, bovine serum albumin; CaM-KIII, calcium/calmodulin dependent protein kinase III; CMFePBS, calcium/ magnesium free PBS; DAG, diacyl-glycerol; DMMB, dimethyl-methylene blue; dNTP, deoxy nucleotide triphosphate; DTT, 1,4-dithio-threitol; ERK, extracellular signalregulated kinase; FGF, fibroblast growth factor; HDC, high density culture; MAPK, mitogen-activated protein kinase; MAPKAP, mitogen-activated protein kinaseactivated protein kinase; PAGE, polyacrilamide gel electrophoresis; PBS, phosphate buffered saline; PBST, phosphate buffered saline and Tween-20; PI, propidium iodide; PKB, protein kinase B; PKC, protein kinase C; PMA, phorbol-12-myristate-13-acetate; PMSF, phenylmethylsulphonyl-fluoride; PRAK, p38-regulated/activated protein kinase; RT, reverse transcription; SDS, sodium-dodecyl-sulphate; TAE, TRISacetate-EDTA buffer.
for Src family kinases. Upon phosphorylation on tyrosine residues, PKCdelta can act as a lipid-independent enzyme [5] . One of its distinguishing characteristics is that unlike other PKC isoforms, PKCdelta activity is also involved in negative regulation of various cellular processes, e.g. suppression of proliferation and survival [6] . PKCdelta is also a crucial component of the cellular stress response, since it is required for apoptotic processes, however, some data suggest that it can also negatively influence apoptosis [7] .
To identify the physiological substrates and multiple roles of various PKC isoenzymes in cellular processes, several protein kinase inhibitors have been developed with a variable specificity for individual kinases. The bisindolylmaleimide GF109203X is a general PKC inhibitor with a more potent effect on cPKC. The indolocarbazole Gö6976 inhibits both cPKC and nPKC [8] . However, the specificity of these pharmacological inhibitors is a rather controversial issue [9] . Some protein kinase inhibitors exhibit variable degrees of specificity for different enzymes at distinct concentrations. A polyphenolic compound [5,7- dihydroxy-2,2-dimethyl-6-(2,4,6-trihydroxy-3-methyl-5-acetylbenzyl)-8-cinnamoyl-1,2-chromene], rottlerin, isolated from a common Indian rain forest tree, Mallotus philippinensis, is reported to inhibit several PKC isoforms, and is thought to selectively inhibit PKCdelta 5e30-fold stronger than other PKCs at 3e6 mM concentration [4] . However, according to the findings of an in vitro enzyme activity measurement campaign conducted by the group of Davies [9] , in which the specificity of various protein kinase inhibitors were assayed, rottlerin was found to inhibit many protein kinases (e.g. PRAK, MAP-KAP-2) much more potently than PKCdelta, and in fact it failed to inhibit in vitro PKCdelta activity. Rottlerin was also described to inhibit some other kinases as Akt/PKB and CaM-KIII at 500 nM [10] . Moreover, in a recent review analysing data of publications describing controversial results gained by the application of rottlerin in order to inhibit PKCdelta, it is concluded that rottlerin can be considered as a mitochondrial uncoupler rather than a direct inhibitor of this enzyme [11] .
Rottlerin modulates a great variety of cellular processes in both malignant and non-malignant cells, including apoptosis in lung cancer, breast cancer, leukaemia and myeloma cells, proliferation in glioma cells, secretory activity of pancreatic acinar cells [12e14], and it is also known to regulate tumour cell migration [15] . Rottlerin has also been described to interfere with the differentiation process of various cell types of mesenchymal origin, exerting its effects at least partially by inhibiting the activity of PKCdelta [16e18] . In a recent study, Choi and his co-workers reported that rottlerin altered the migration of prechondrogenic mesenchymal cells in chicken limb bud high density cultures by modulating integrin b1-signalling at focal adhesion complexes via a PKCdeltaindependent mechanism [10] .
In this study we applied the same in vitro chondrogenesis model, in which high density cell cultures are established from chondrogenic mesenchymal cells isolated from limb buds of chicken embryos. In HDC, formation of cartilage starts with the condensation of chondroprogenitor mesenchymal cells on the first day, that after nodule formation differentiate into chondroblasts and chondrocytes predominantly on the second and third days of culturing [19] . Steps of this differentiation process are regulated by numerous growth factors and other soluble morphogens [20] and differentiating cells start to secrete cartilage-specific extracellular matrix components, such as collagen type II and aggrecan on the third day of culturing [21] . Expression of cartilage-specific matrix molecules is regulated by Sox9, a high-mobility-group domain containing transcription factor, which is started to be expressed as soon as mesenchymal cells become committed toward the chondrogenic lineage [22] . Detection of the mRNA and protein expression level and the phosphorylation status of Sox9, as well as monitoring the expression of the core protein of aggrecan and collagen type II are reliable markers of in vitro chondrogenesis.
Here we provide evidence that PKCdelta is expressed by cells of chondrifying chicken limb bud high density cultures throughout their entire differentiation process. Administration of rottlerin to cells of HDC resulted in a time and concentration dependent inhibition of metachromatic cartilage matrix production and caused a marked decrease in the phosphorylation of both Sox9 and ERK1/2, but we failed to unambiguously demonstrate inhibition of PKCdelta activity with this compound. PKCdelta gene silencing significantly lowered the activity of PKC, abolished cartilage matrix production and decreased the level of phosphorylated Sox9, but elevated the phosphorylation of ERK1/2. Our results indicate that PKCdelta acts as a positive regulator of in vitro chondrogenesis via modulation of the ERK1/2 and Sox9 pathways. Nevertheless, the chondrogenesisinhibiting effect of rottlerin is probably exerted via a PKCdeltaindependent manner, therefore we do not recommend administration of rottlerin for PKCdelta inhibition in high density cell culture systems.
Materials and methods

Cell culturing
Distal parts of the limb buds of Ross hybrid chicken embryos (HamburgereHamilton stages 22e24) were removed and primary micromass cultures of chondrifying mesenchymal cells were established from cell suspensions with a density of 1.5 Â 10 7 cells/ mL. 100e100 mL droplets of the suspension were inoculated into plastic Petri dishes (Orange Scientifique, Braine-l'Alleud, Belgium). Day of inoculation is considered as day 0. After 2 h, colonies were nourished with Ham's F12 medium (Sigma, St. Louis, MO, USA), supplemented with 10% fetal calf serum (Gibco, Gaithersburg, MD, USA) and were kept at 37 C in the presence of 5% CO 2 and 80% humidity in a CO 2 incubator. The medium was changed on every second day.
Transient gene silencing and pharmacologic inhibition of PKCdelta
PKCdelta shRNA (GenScript USA Inc., Piscataway, NJ, USA) was cloned into GeneSwitchÔ, the inducible protein expression system from Invitrogen (Invitrogen, Carlsbad, CA, USA). Plasmids were amplified using competent E. coli bacteria from One Shot chemical transformation kit (Invitrogen). Ampicillin or hygromycin resistant bacteria were grown on LB agar, and plasmids were isolated using MaxiPrep kit (QIAGEN, Valencia, CA, USA) according to the protocol of the manufacturer. Plasmids were delivered into cells of chondrifying cell cultures by using Lipofectamine 2000 (Invitrogen) transfection reagent. Lipofection delivery system protocol was performed on freshly isolated cell suspensions with a density of 1. 
Measurement of apoptosis and necrosis by flow cytometry
After 24 h of transfection or treatments with rottlerin, rate of apoptosis was measured by using AnnexinV DY 647 kit (Central European Biosystems, Budapest, Hungary). Mock-transfected cells (cultures treated only with the transfection reagent) or untreated cultures were used as control. After washing twice in CMFePBS (calcium and magnesium free phosphate buffered saline), cells were incubated with 10 mL AnnexinV DY 647 at room temperature for 10 min. Before harvesting with 0.25% trypsin (Sigma) cells were washed with Annexin binding buffer. Necrosis was measured by using propidium-iodide (PI, Invitrogen). Cells were washed in CMFePBS and 2 mL PI was added at room temperature for 10 min in a dark chamber. Cell pellets were resuspended in 500 mL FACS buffer (PBS supplemented with 1% BSA and 0.05% NaN 3 ) and measured on a CyFlow Ò space Flow Cytometer (Partec GmbH, Münster, Germany). PI was monitored at 617 nm and Annexin DY647 at 670 nm. Measurement lower threshold was set on cellsize particles. Analysis was performed with WinMDI 2.8 freeware (Joseph Trotter; http://facs.scripps.edu/).
Preparation of cell extracts
Chondrifying cell cultures were washed with physiological NaCl solution and were harvested on different days of culturing. After centrifugation cell pellets were suspended in 100 mL of a homogenization buffer containing 50 mM Tris-HCl buffer (pH 7.0), 0.5 mM 1,4-dithio-threitol (DTT), 10 mg/mL Gordox, 10 mg/mL leupeptin, 1 mM phenylmethylsulphonyl-fluoride (PMSF), 5 mM benzamidine, 10 mg/mL trypsin inhibitor as protease inhibitors, and 0.5% Triton X-100. Samples were snap-frozen in liquid nitrogen, then stored at À70 C. Suspensions were sonicated by pulsing burst for three times 30 s by 50 cycles (Cole Palmer Ultrasonic distributor, Illinois, USA). For Western blotting and for PKCdelta activity assays, total cell lysates were used. For RT-PCR analysis, cartilage colonies were washed three times with RNase-free physiological NaCl, then the cultures were stored at À70 C.
RT-PCR analysis
Cell cultures were dissolved in Trizol (Applied BioSystems), 20% RNase-free chloroform was added and the samples were centrifuged at 4 C at 10,000 Â g for 15 min. Samples were incubated in 500 mL of RNase-free 2-propanol in À20 C for 1 h, total RNA was harvested in RNase-free water and stored at À20 C. The assay mixture for reverse transcriptase reaction contained 2 mg RNA, 0.112 mM oligo(dT), 0. Optical density of signals was measured by using ImageJ 1.40 g freeware and results were normalised to the optical density of untreated control cultures.
Western blot analysis
Total cell lysates were examined by Western blot. Samples for SDS-PAGE were prepared by adding 1/5 volume of fivefold concentrated electrophoresis sample buffer (310 mM TriseHCl pH 6.8, 10% SDS, 50% glycerol, 100 mM DTT, 0.01% bromophenol blue) to cell lysates and boiled for 10 min. About 70e80 mg of protein was separated by 10% SDS-PAGE gel for detection of PKCdelta, Sox9, p-Sox9, ERK1/2 and p-ERK1/2. Proteins were transferred electrophoretically to nitrocellulose membranes. After blocking in 5% non-fat dry milk in PBST (phosphate buffered saline with 0.1% Tween 20; 20 mM Na 2 HPO 4 , 115 mM NaCl; pH 7.4), membranes were washed and exposed to the primary antibodies overnight at 4 C. Polyclonal anti-PKCdelta antibody (Santa Cruz Inc., CA, USA) in 1:100, polyclonal anti-Sox9 antibody (Abcam, Cambridge, UK) 241  242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272  273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305   306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339  340  341  342  343  344  345  346  347  348  349  350  351  352  353  354  355  356  357  358  359  360  361  362  363  364  365  366  367  368  369 in 1:600, polyclonal anti-p-Sox9 antibody (Sigma) in 1:600, polyclonal anti-ERK1/2 antibody (Sigma) in 1:1000, and polyclonal anti-MAP kinase (diphosphorylated ERK1/2 on Thr and Tyr residues; Sigma) in 1:600 dilution were used. After washing three times for 10 min with PBST, membranes were incubated with the secondary antibody, anti-rabbit IgG (Bio-Rad Laboratories, CA, USA) in 1:1000 dilution in PBST containing 1% non-fat dry milk for 2 h at room temperature. Signals were detected by enhanced chemiluminescence (Millipore, Billerica, MA, USA) according to the instructions of the manufacturer. Optical density of signals was measured by using ImageJ 1.40 g freeware (downloaded from: http://rsb.info.nih.gov/ij/) and results were normalised to the optical density of untreated control cultures.
Total PKC and PKCdelta enzyme activity measurements
For PKC activity assays, cells were harvested and after centrifugation at 10,000 Â g for 10 min at 4 C, supernatants were used for enzyme activity measurements. PKC activity was assayed by measuring the incorporation of 32 P incorporation into histone IIIS were carried out by pipetting 30 mL of the reaction mixture on filter paper squares (Whatman P81, 2 Â 2 cm) after 20 min reaction time. All papers were washed three times in 0.5% phosphoric acid, dried and counted for radioactivity in a liquid scintillation counter. For measurements of PKCdelta activity, rottlerin (10 mM) was administered to the reaction mixtures, and the difference caused by this compound in the total PKC activity was considered to be the contribution of PKCdelta to the overall PKC activity.
Data processing and statistical analysis
To determine the metachromatic cartilage matrix production, optical density of toluidine blue-stained cultures (OD 625 nm ) was measured in samples from 3 cultures of each experimental group in 3 independent experiments. For the detection of cellular proliferation rate ( 3 Hethymidine incorporation assay) or mitochondrial activity (MTT assay), measurements were carried out in 10 samples of each experimental group in 4 independent experiments. Data are mean values AE standard error of the mean and were statistically analysed with Student's t-test (P < 0.01). Data analysis of FACS measurement results was performed with WinMDI 2.8 freeware (Joseph Trotter; http://facs.scripps.edu/). For RT-PCR reactions and Western blot analyses, optical density of signals was measured by using ImageJ 1.40 g freeware and results were normalised to the optical density of untreated control cultures. Data of PKC enzyme activity measurements were statistically analysed with Student's t-test (P < 0.01).
Results
PKCdelta expression and activity in cells of HDC
To identify the mRNA and protein expression pattern of PKCdelta during in vitro chondrogenic differentiation of chicken mesenchymal cells, RT-PCR reactions and Western blot analyses were performed, respectively. The mRNA sequence of chicken PKCdelta was downloaded from GenBank and a specific primer pair was designed for amplification.
mRNA expression of chicken PKCdelta in cells of HDC followed an unchanged pattern during differentiation from day 0, with only slightly higher expression levels on days 1 and 2 (Fig. 1A) . The protein expression profile of chicken PKCdelta, however, followed a peak-like pattern and showed an almost four-fold elevation by days 2 and 3 compared to day 0, as revealed by Western blot analyses (Fig. 1B) . Under control conditions, the enzyme activity of PKCdelta in cells of HCD exhibited a pattern that is closely correlated with the protein expression, i.e. the enzyme activity was higher on days 1e4 compared to day 0. Activity of PKCdelta then decreased toward the end of the culturing period (Fig. 1C) . 501  502  503  504  505  506  507  508  509  510  511  512  513  514  515  516  517  518  519  520  521  522  523  524  525  526  527  528  529  530  531  532  533  534  535  536  537  538  539  540  541  542  543  544  545  546  547  548  549  550  551  552  553  554  555  556  557  558  559  560  561  562  563  564  565   566  567  568  569  570  571  572  573  574  575  576  577  578  579  580  581  582  583  584  585  586  587  588  589  590  591  592  593  594  595  596  597  598  599  600  601  602  603  604  605  606  607  608  609  610  611  612  613  614  615  616  617  618  619  620  621  622  623  624  625  626  627  628  629  630 the following set of experiments we only used the concentration of 5 mM.
Since the observed decrease in metachromatic staining could have been caused by cytotoxic and/or anti-proliferative effects of rottlerin, mitochondrial activity and cellular proliferation assays were performed, respectively. Rottlerin administered on days 2 and 3 for 4 h in 5 mM concentration caused a slight, but significant decrease in metabolic activity in cells of HDC and it also caused a significant decrease in proliferation rate as revealed by MTT and radioactively labelled thymidine incorporation assays, respectively (Fig. 2B) . Rottlerin treatments did not result in the elevation of apoptotic or necrotic rate in cells of HDC in either concentration according to FACS analyses (data are shown in the Supporting information).
To evaluate the role of rottlerin in the molecular regulation of in vitro chondrogenesis, mRNA and protein levels of PKCdelta, aggrecan core protein and Sox9, the major cartilage-specific transcription factor, were detected by RT-PCR and Western blot reactions, respectively. Exposure to rottlerin resulted in a marked decrease in the mRNA expression of PKCdelta (Fig. 3A) , however, only a slight reduction was observed in its protein expression level when rottlerin was applied at a concentration of 5 mM (Fig. 3B) . A significant decrease in the mRNA levels of both aggrecan core protein and Sox9 was detected under the effect of rottlerin treatments (Fig. 3A) . Western blot analyses showed that exposure to 5 mM rottlerin only slightly reduced the protein level of Sox9, whereas a significant decrease was observed in its phosphorylation level after the administration of the inhibitor (Fig. 3B ). These findings demonstrate that rottlerin decreases cartilage formation, at least partly, via inhibition of cartilage differentiation.
Since MAP-kinases, particularly ERK1/2 is one of the key regulators that influence in vitro chondrogenesis, we examined whether the observed decrease in cartilage matrix production was regulated by an ERK1/2 dependent pathway. Although administration of rottlerin did not alter the mRNA expression level of ERK1/2 and protein expression was also only slightly modified, exposure to 5 mM rottlerin significantly reduced the level of phosphorylated ERK1/2 (Fig. 3AeB) . Furthermore, administration of 5 mM rottlerin to cells on days 2 and 3 caused alterations in the activity of PKCdelta measured on day 3 of culturing in cell-free extracts of HDC, but the direction of these changes was completely inconsistent (data not shown). These findings suggest that the aforementioned effects of rottlerin on cartilage differentiation could have mostly been caused by its aspecific, non-PKCdelta-dependent effects.
Inhibition of PKCdelta by shRNA transfection inhibits in vitro chondrogenesis
Although rottlerin is widely known as a selective inhibitor of PKCdelta, some data are available on its PKCdelta-independent effects [24] and our results also suggested such a possibility. Therefore, we selectively inhibited PKCdelta expression using specifically designed shRNA to clarify the role of PKCdelta in chondrogenesis. The PKCdelta shRNA sequence was cloned into GeneSwitch, the inducible protein expression system from Invitrogen, and transfected into primary chondroprogenitor mesenchymal cells on day 0, prior to their attachment by using Lipofectamine 2000 transfection reagent. On day 2 of culturing, 1 mM mifepristone was added to the culture medium for 24 h for the induction of GeneSwitch System. Mifepristone at the applied concentration did not alter the amount of in vitro cartilage matrix production by culturing day 6 (data are shown in the Supporting information).
Introduction of empty GeneSwitch vector alone into cells of HDC resulted in a significant decrease of metachromatic cartilage matrix production (40% of mock-transfected control cultures) as revealed by dimethyl-methylene blue and toluidine blue staining procedures on day 6 of culturing ( Fig. 4A) . Introduction of PKCdelta shRNA-containing GeneSwitch resulted in an even stronger inhibition (5% of mock-transfected control cultures), and the complete loss of the metachromatic cartilage matrix (Fig. 4A) .
In spite of the pronounced inhibition of cartilage matrix production, mitochondrial activity of cells transfected with either empty or PKCdelta shRNA-containing GeneSwitch constructs remained unchanged compared to mock-transfected control cells as revealed by MTT assays, and the rate of cellular proliferation also did not show any alterations in either case (Fig. 4B) . Cellular viability and apoptosis assays performed by measuring the ratio of propidium iodide and Annexin V DY647 stained cells using FACS analysis revealed that transfection with the empty vector did not cause any change in these parameters, whereas introduction of the PKCdelta shRNA vector resulted in a very slight elevation of apoptotic (2%) and necrotic (1%) cell death (Fig. 4C ). These findings demonstrate that the observed decrease in cartilage matrix production was not caused by altered cellular viability, mitochondrial activity, proliferation or apoptotic rate.
We also wanted to examine the signalling mechanism underlying the aforementioned alterations of in vitro cartilage matrix production. To evaluate the efficiency of gene silencing, RT-PCR and Western blot analyses were performed. Although mRNA expression of PKCdelta decreased only to a lesser extent as a result of shRNA expression (Fig. 5A) , however, at the protein level it exhibited a marked inhibition (30% of cultures transfected with the empty vector) reflecting on the efficiency of PKCdelta gene silencing (Fig. 5B) . While PKCdelta gene silencing did not change the mRNA expression of Sox9, and the mRNA level of aggrecan core protein only exhibited slight alterations, the protein level of Sox9 showed a marked decrease as a result of introduction of PKCdelta shRNA, as revealed by RT-PCR and Western blot analyses, respectively (Fig. 5AeB) . Although PKCdelta gene silencing did not affect either the mRNA or the protein expression of ERK1/2, a significant (twofold) increase in its phosphorylated form was observed, implicating the involvement of this pathway in the signal transduction mechanism of PKCdelta in cells of chondrifying micromass cultures. Administration of either the empty or the PKCdelta shRNA-containing vector resulted in a significant decrease in PKC activity of cells in HDC, with a more than 50% reduction in cultures transfected with PKCdelta shRNA (Fig. 5C ) as compared to mock-transfected cultures.
Protein expression and phosphorylation status profiles of Sox9 and ERK1/2 exhibit a time-dependent pattern in differentiating HDC
Since both the cartilage-specific transcription factor Sox9 and the dual-specificity MAPK ERK1/2 are key regulators of in vitro chondrogenesis, and their activity can be modified by reversible phosphorylation, we examined their protein expression as well as the phosphorylation status pattern in untreated control cultures during the 6-day-long culturing period. As shown in Fig. 6 , the protein expression profiles of ERK1/2 and its dual phosphorylated (fully active) form demonstrate that the activity of ERK1/2 is the highest in young chondroblasts (i.e. in cells of 3-day-old HDC) and becomes lower in differentiated chondrocytes (6-day-old HDC). Although Sox9 is readily expressed in chondroprogenitor mesenchymal cells (0-day-old HDC), we detected a 5-fold elevation in 2-day-old cultures, when the cells start their differentiation programme. In differentiated cultures, Sox9 expression shows Fig. 4 . Effect of PKCdelta gene silencing on cartilage matrix production in high density micromass cultures (A). Metachromatic cartilage areas in 6-day-old high-density colonies visualised with DMMB dissolved in 3% acetic acid. Optical density (OD 625 ) of samples containing toluidine blue extracted with 8% HCl dissolved in absolute ethanol. Data shown are mean values AE standard error of the mean (AE5%) of each experimental group out of 10 measurements. Asterisk indicates significant (*P < 0.01) decrease in optical density of extracted toluidine blue as compared to the respective control (mock-transfected cultures). Effects of PKCdelta gene silencing on mitochondrial activity and cellular proliferation (B) of cells in 3-day-old HDC. Empty columns represent mitochondrial activity and cellular proliferation rate of cultures transfected with the empty vector (GeneSwitch), gray columns represent mitochondrial activity and cellular proliferation of HDC transfected with the PKCdelta shRNA-containing vector. Mitochondrial activity was measured by MTT assay and cell proliferation was assessed by a decrease, but it does not reach the baseline level again. Changes in the phosphorylation level of Sox9 are not significant, nonetheless, it exhibits a similar pattern (Fig. 6 ).
Discussion
It has long been known that various PKC isoenzymes are involved in the chondrogenic differentiation of chicken limb micromass cultures. PKC enzyme activity proved to be detectable in cells of HDC with characteristic changes during differentiation, and conversely, exposure of cultures to long-term phorbol-12-myristate-13-acetate (PMA) treatments blocked the differentiation process and abolished in vitro cartilage matrix production [25] . In a study conducted by Choi and his colleagues the expression profiles of classic (PKCalpha and gamma), novel (PKCepsilon) and atypical (PKCzeta, lambda and iota) protein kinase C isoenzymes have been described during the differentiation of chicken micromass cultures and they showed that expression of various cPKC and nPKC isoforms is mostly required at the early stages of in vitro cartilage formation [3] . However, Choi and his group failed to detect PKCdelta expression in cells of HDC with the antibodies employed [3] . It has also been reported that protein kinase A signalling regulates in vitro chondrogenesis of chicken mesenchymal cells via the PKCalpha pathway [26] . PKCdelta expression in cells of HDC was reported for the first time by Grill and his colleagues, who confirmed its protein expression by immunochemical and immunocytochemical approaches [27] . Recently, Choi and his colleagues demonstrated the protein expression of PKCdelta by Western blot analyses in cells of HDC [10] , when they investigated the involvement of this signal molecule in the regulation of the formation of prechondrogenic nodules. Consistent with their data, our results also showed a marked increase in PKCdelta protein expression at the beginning of the 6-day-long culturing period, followed by a decrease in its expression level. We also confirmed these findings by PKCdelta enzyme activity assays, with the maximum levels of activity corresponding to the highest levels of protein expression on culturing days 1e4. Correspondence of these patterns to the onset of chondrogenic differentiation of cells in HDC supports our idea that PKCdelta is a good candidate among PKC isoforms to be involved in the regulation of signalling mechanisms leading to in vitro cartilage formation.
In the subsequent set of experiments rottlerin (mallotoxin), described as an inhibitor of PKCdelta activity in some publications [28e30], was administered to cells of HDC. Rottlerin treatments resulted in a decrease of cartilage matrix production in a concentration and time dependent manner, including days 1 or 2 of culturing, when condensation and nodule formation of chondrogenic mesenchymal cells take place. These results are in agreement with the findings of Choi and his colleagues, who reported that rottlerin, via modulation of Akt-signalling and integrin b1-mediated pathways, might be negatively involved in the regulation of the migratory potential of chondroprogenitor cells in chicken limb bud-derived HDC, but in a PKCdelta-independent manner [10] .
Since the decrease in metachromatic cartilage matrix production we observed might have resulted from the reduced cellular viability and/or decreased cellular proliferation rate, mitochondrial oxidase activity (MTT) and proliferation (radioactively labelled thymidine incorporation) assays were performed. While the cellular viability was only lowered to a lesser, but still significant extent, a more pronounced decrease in the rate of proliferation was observed. The latter result is consistent with the anti-proliferative effect of rottlerin on HaCaT keratinocytes [24] . Administration of rottlerin did not induce either apoptosis or necrosis in cells of HDC. As rottlerin is described as a mitochondrial uncoupler of different mammalian cell types rather than a direct PKCdelta inhibitor in some recent publications [11, 31] , these findings may reflect on a difference in mitochondrial sensitivity to rottlerin of chicken compared to mammalian cells. mRNA and protein expression of Sox9, the key chondrogenic transcription factor decreased after rottlerin treatments, moreover, phosphorylation of Sox9 (resulting in a more active form of this transcription factor) was almost completely abolished. The observed decrease in the phosphorylated form of Sox9 protein could be, at least partially, accounted for the reduced cartilage matrix production after the administration of rottlerin.
The ERK pathway, also known as the MEK-ERK kinase cascade, is one of the key cytoplasmic signal transduction pathways governing proliferation, survival and differentiation of eukaryotic cells. The role of this crucial signal pathway in the regulation of chondrogenesis is rather controversial and probably depends either on the experimental model or/and the methods applied. ERK1/2 was reported as a negative regulator of chondrogenesis in both HDC [32, 33] and C3H10T mouse embryonic mesenchymal cells [34] . In these experiments the function of ERK1/2 was assessed by the application of pharmacological inhibitors PD098059 or U0126 [35] . On the contrary, it seemed to promote chondrogenesis in adult human bone marrow derived multipotent progenitor cells when the gene silencing technique was the approach [36] . Nonetheless, we found that the protein expression profiles of ERK1/2 and its dual phosphorylated (fully active) form show that the activity of ERK1/2 is the highest in young chondroblasts (i.e. in cells of 3-day-old HDC) and becomes lower in differentiated chondrocytes (i.e. 6-day-old HDC) (Fig. 6 ). In our current experiments neither the mRNA, nor the protein expression of ERK1/2 was altered after treatments with rottlerin, but its phosphorylated form was almost completely diminished. Our results correspond with that of another study conducted by Tapia and his colleagues on pancreatic acinar cells, where rottlerin also proved to inhibit MAPK-activation [14] .
Since rottlerin has been described as a factor having both PKCdelta dependent and independent effects often leading to contradictory results on various tissue and cell types [14, 24] , we were prompted to apply targeted PKCdelta mRNA silencing to clarify the role of PKCdelta activity during the differentiation of chondrogenic mesenchymal cells. Transfection with PKCdelta shRNA and subsequent transient gene silencing of cellular PKCdelta almost completely blocked in vitro chondrogenesis. Neither mitochondrial activity, nor cellular proliferation rate were significantly affected by the introduction of either the empty or the PKCdelta shRNA-containing vectors into cells of HDC, furthermore, PKCdelta gene silencing did not induce significant apoptotic and/or necrotic cell death rate of chondrogenic cells. In contrast to our results, PKCdelta has been reported as an accelerator of proliferation in cultured human skeletal muscle cells and C2C12 myoblast cells during myogenic differentiation, although the authors applied rottlerin to investigate the effects of the inhibition of PKCdelta in these experiments [37] . In our experiments, administration of either the empty or the PKCdelta shRNA-containing vector into cells of HDC caused a significant decrease in PKC activity assayed on day 3. The approximately 70% decrease in PKC activity values detected in HDC transfected with the shRNA-containing vector may reflect on the fact that reduction of the efficacy of chondrogenesis itself could have led to an inhibition of PKC activity. Another possibility is that PKCdelta might be involved in the regulation of the activity of other members of the PKC family. This idea is based on the theory of Toker, who proposed that some PKC isoenzymes can activate other PKCs via phosphorylation in a cascade-like manner [38] .
Since PKCdelta gene silencing effectively decreased PKC enzymatic activity and led to an almost complete inhibition of in vitro cartilage matrix production, the expression of the molecular regulators of chondrogenesis was also investigated. While the mRNA expression of Sox9 was not affected, its protein expression and phosphorylation were markedly reduced as a result of the introduction of PKCdelta shRNA, and this reduction can partially be accounted for the observed effects on metachromatic cartilage matrix production. Inhibition of PKCdelta activity in osteoblasts by using siRNA has led to a decrease in the phosphorylation and activity of ERK1/2, which in turn has suppressed the differentiation of diosmetin-induced differentiation of these cells [39] . On the contrary, activation of PKCdelta was found to decrease the activity of ERK1/2 in keratinocytes [40] . Moreover, PKCdelta altered differently the phosphorylation of ERK1/2 in human primary skeletal muscle cells and C2C12 rat myogenic cells [37] . Although neither the mRNA nor the protein expression of ERK1/2 showed any alterations as a result of PKCdelta gene silencing in our experimental system, the level of its phosphorylated form exhibited a two-fold increase. If the observation that younger chondroblasts have the highest ERK activity in HDC is taken into consideration, it seems to be plausible to conclude that the persistently elevated ERK1/2 activity may block further differentiation of chondroblasts and in this way could be a factor involved in the complete inhibition of in vitro cartilage matrix production following PKCdelta gene silencing. However, application of gene silencing of PKCdelta had variable effects on MEK-ERK1/2 signalling pathway in different systems [39, 41, 42] , but the majority of the investigations describes PKCdelta as a negative regulator of MEK-ERK1/2 pathway [43] . As we failed to detect any elevation in the phosphorylation of ERK1/2, instead, we found a decreasing pattern following the application of rottlerin, therefore we suppose that this compound is probably not a PKCdelta inhibitor in HDC. This idea is further supported by the fact that we were unable to detect any consistent change of PKCdelta enzyme activity in our experiments when rottlerin was applied to the culture medium of cells for 4e4 h on days 2 and 3. However, when rottlerin was added to the reaction mixtures of total PKC enzyme activity assays performed in cell free samples prepared from untreated HDC, it resulted in significantly lower enzyme activities. Nonetheless, the contradiction can be resolved if we hypothesise that rottlerin might have different effects when applied to cells or to an in vitro enzyme activity assay. As we have already mentioned, rottlerin has been described as a mitochondrial uncoupler in different cells [11] , and a wide range of its effects (including indirect inhibition of PKCdelta) can be regarded as a consequence of this phenomenon.
Taken together, our results suggest that PKCdelta is a positive regulator of in vitro chondrogenesis upstream to the protein expression and phosphorylation of Sox9. Since the activity of ERK1/2 was increased by PKCdelta gene silencing, PKCdelta could also be a negative regulator of the ERK1/2 kinase pathway in HDC. However, our results concerning the involvement of PKCdelta in the MAPK pathway seem to be controversial, as inhibition of PKCdelta activity by rottlerin and PKCdelta gene silencing has led to opposing results. Nevertheless, the apparent confusion can be resolved if the PKCdelta-independent effects of rottlerin are also taken into consideration: rottlerin is reported to inhibit other PKC isoforms as well as other kinases, such as p38-regulated kinase, MAPK-activated protein kinase 2, PKA or CaM-KIII and it can also modulate mitochondrial metabolic processes [11, 14] . Because of its diverse and probably non-PKCdelta-specific effects, we do not recommend application of rottlerin as an approach for investigating the role of PKCdelta in chondrifying high density micromass cultures.
Conclusions
The main findings of this work can be summarised as follows. The continuously detectable PKCdelta expression and activity exhibited a peak on days 2 and 3, when chondrogenic cells differentiate into chondroblasts in HDC. Rottlerin decreased PKC activity in a cell-free assay system, but failed to inhibit PKC activity when it was applied to HDC during culturing. Gene silencing resulted in a significantly lower PKC activity. Both rottlerin and PKCdelta shRNA caused a severe reduction in cartilage formation as well as in the protein and phospho-protein levels of Sox9. Rottlerin reduced, while PKCdelta gene silencing elevated the phosphorylation status of ERK1/2. On the basis of our results, we concluded that PKCdelta stimulates in vitro chondrogenesis via influencing Sox9 and ERK1/2 phosphorylation, but inhibition of cartilage formation in the rottlerin-treated HDC is presumably a PKCdelta-independent process. 1151  1152  1153  1154  1155  1156  1157  1158  1159  1160  1161  1162  1163  1164  1165  1166  1167  1168  1169  1170  1171  1172  1173  1174  1175  1176  1177  1178  1179  1180  1181  1182  1183  1184  1185  1186  1187  1188  1189  1190  1191  1192  1193  1194  1195  1196  1197  1198  1199  1200  1201  1202  1203  1204  1205  1206  1207  1208  1209  1210  1211  1212  1213  1214  1215 
